THE ROLE OF STRESS AND PSYCHOEMOTIONAL FACTORS IN THE DEVELOPMENT AND EXACERBATION OF ECZEMA
DOI:
https://doi.org/10.55475/jcgtm/vol5.iss5.2026.725Keywords:
Eczema, skin barrier, emollients, transepidermal water loss, Staphylococcus aureus, atopic dermatitis, infectious complicationsAbstract
Eczema is a chronic inflammatory skin disease characterized by a severe defect in the epidermal barrier and frequent secondary infectious complications. This study aims to comprehensively evaluate the clinical efficacy of emollient therapy in restoring the skin barrier and reducing susceptibility to bacterial colonization. Utilizing a randomized clinical trial design, one hundred and fifty patients presenting with moderate to severe eczema were evaluated at regional dermatological and infectious disease centers. The intervention group received a standardized ceramide-dominant emollient regimen alongside conventional therapy, while the control group received conventional therapy alone. Clinical assessments included the SCORAD index, transepidermal water loss measurements and microbiological swabbing for Staphylococcus aureus over a twelve-week period.
The literature review highlights the critical role of filaggrin mutations and lipid matrix deficiencies in the pathogenesis of eczema, emphasizing that barrier dysfunction precedes clinical inflammation. Our empirical results demonstrate a statistically significant reduction in both transepidermal water loss and bacterial colonization rates in the emollient group compared to the control group. Patients utilizing the barrier repair therapy experienced fewer exacerbations and required less topical corticosteroid application. The discussion contextualizes these findings within the broader framework of infectious disease prevention, arguing that proactive skin barrier restoration is not merely symptomatic relief but a fundamental pathophysiological intervention.
In conclusion, the systematic application of advanced emollients is mandatory for optimal eczema management, effectively disrupting the cycle of barrier impairment and secondary infection.
References
1. Proksch, E., Brandner, J. M., & Jensen, J. M. (2008). The skin - an indispensable barrier. Experimental Dermatology, 17(12), 1063-1072. DOI: https://doi.org/10.1111/j.1600-0625.2008.00786.x
2. Kong, H. H., Oh, J., Penn, C., Zeitels, L., Bouffard, G. G., Mullikin, J. C., ... & Segre, J. A. (2012). Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Research, 22(5), 850-859. DOI: https://doi.org/10.1101/gr.131029.111
3. Palmer, C. N., Irvine, A. D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S. P., ... & McLean, W. H. (2006). Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics, 38(4), 441-446. DOI: https://doi.org/10.1038/ng1767
4. Janssens, M., van Smeden, J., Gooris, G. S., Bras, W., Portale, G., Caspers, P. J., ... & Bouwstra, J. A. (2012). Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. Journal of Lipid Research, 53(12), 2755-2766. DOI: https://doi.org/10.1194/jlr.P030338
5. Simpson, E. L., Chalmers, J. R., Hanifin, J. M., Thomas, K. S., Cork, M. J., McLean, W. H., ... & Williams, H. C. (2014). Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. Journal of Allergy and Clinical Immunology, 134(4), 818-823. DOI: https://doi.org/10.1016/j.jaci.2014.08.005
6. Cork, M. J., Danby, S. G., Vasilopoulos, Y., Hadgraft, J., Lane, M. E., Moustafa, M., ... & Ward, S. J. (2009). Epidermal barrier dysfunction in atopic dermatitis. Journal of Investigative Dermatology, 129(8), 1892-1908. DOI: https://doi.org/10.1038/jid.2009.133
7. Eichenfield, L. F., Tom, W. L., Berger, T. G., Krol, A., Paller, A. S., Schwarzenberger, K., ... & Silverman, R. A. (2014). Guidelines of care for the management of atopic dermatitis - section 2. Management and treatment of atopic dermatitis with topical therapies. Journal of the American Academy of Dermatology, 71(1), 116-132. DOI: https://doi.org/10.1016/j.jaad.2014.03.023
8. Wollenberg, A., Barbarot, S., Bieber, T., Christen-Zaech, S., Deleuran, M., Gauger, A., ... & European Dermatology Forum (EDF). (2018). Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children - part I. Journal of the European Academy of Dermatology and Venereology, 32(5), 657-682. DOI: https://doi.org/10.1111/jdv.14891
9. Tauber, M., Balica, S., Hsu, C. Y., Jean-Decoster, C., Lauze, C., Redoules, D., ... & Simon, M. (2015). Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis. Journal of Allergy and Clinical Immunology, 137(4), 1272-1274. DOI: https://doi.org/10.1016/j.jaci.2015.07.052
10. Danby, S. G., Al-Enezi, T., Sultan, A., Chittock, J., Kennedy, K., English, J., ... & Cork, M. J. (2022). The effect of water hardness on surfactant-induced epidermal barrier damage. Journal of Investigative Dermatology, 138(3), 689-697.
11. Macheleidt, O., Kaiser, H. W., & Sandhoff, K. (2002). Deficiency of epidermal protein-bound linoleic acid in atopic dermatitis. Journal of Investigative Dermatology, 119(1), 166-173. DOI: https://doi.org/10.1046/j.1523-1747.2002.01833.x
12. Leung, D. Y., & Guttman-Yassky, E. (2014). Deciphering the complexities of atopic dermatitis - shifting paradigms in treatment approaches. Journal of Allergy and Clinical Immunology, 134(4), 769-779. DOI: https://doi.org/10.1016/j.jaci.2014.08.008
13. Chamlin, S. L., Kao, J., Frieden, I. J., Sheu, M. Y., Fowler, A. J., Fluhr, J. W., ... & Elias, P. M. (2002). Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis - changes in barrier function provide a sensitive indicator of disease activity. Journal of the American Academy of Dermatology, 47(2), 198-208. DOI: https://doi.org/10.1067/mjd.2002.124617
14. Elias, P. M., & Steinhoff, M. (2008). Outside-to-inside (and now back to outside) pathogenic mechanisms in atopic dermatitis. Journal of Investigative Dermatology, 128(5), 1067-1070. DOI: https://doi.org/10.1038/jid.2008.88
Downloads
Published
How to Cite
License
Copyright (c) 2026 Nargiz Baxadirovna Nasritdinova,Bekmirza Xolmirzayevich Toshpo'latov

This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors of the articles published in this magazine are responsible for the scientific news and research results. This copyright is defined according to the international rule "Creative Commons "Attribution" 4.0".